REGISTERED
on 20 Jul 2021
Last Applicant/ Owned by
Sino-Singapore Guangzhou Knowledge City
Guangzhou
CN
510006
Serial Number
88697269 filed on 18th Nov 2019
Registration Number
6429133 registered on 20th Jul 2021
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
SALMET-VEC
Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Protein arrays for diagnosing cancer; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Tumor suppressing agent Read More
Classification Information
Class [005]
Pharmaceutical Products
Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Protein arrays for diagnosing cancer; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Tumor suppressing agents; all containing in whole or significant part, gene therapy substances
First Use Date in General
12th Nov 2020
First Use Date in Commerce
12th Nov 2020
Mark Details
Serial Number
No 88697269
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 07th Dec 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 07th Dec 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 07th Dec 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 20th Jul 2021 | REGISTERED-PRINCIPAL REGISTER |
| 15th Jun 2021 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 14th Jun 2021 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 11th Jun 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 11th Jun 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 11th Jun 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 02th Mar 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |